Stock listing

Nxera Pharma Co., Ltd.

Selected listing: A0B7EK · LS · EUR · DE

Nxera Pharma Co., Ltd. (Lang & Schwarz: A0B7EK), Health Technology. Latest release Oct 1, 2026: Nxera Announces Successful Resolution of miniG Patent…

A0B7EK:LSEURDEUpdated September 26, 2026

Ticker: Lang & Schwarz: A0B7EK
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Nxera Pharma Co., Ltd.

Nxera Announces Successful Resolution of miniG Patent Infringement Action

October 1, 2026

Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress

September 3, 2026

Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition

August 26, 2026

Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026

August 7, 2026

Nxera Pharma Webinar for Financial Results Presentation - 2Q2026

July 15, 2026

All Nxera Pharma Co., Ltd. news →

Events

Replays

Nxera Pharma Co Ltd (SOLTF) Q2 2026 Earnings Call
Fri, Aug 07, 2026 · 04:00 AM ET
Watch
Nxera Pharma Co Ltd (SOLTF) Q4 2025 Earnings Call
Fri, Feb 13, 2026 · 03:00 AM ET
Watch
Nxera Pharma Co Ltd (SOLTF) Q2 2025 Earnings Call
Fri, Aug 08, 2025 · 12:00 AM ET
Watch

Research Nxera Pharma Co., Ltd.

Nxera Pharma Co., Ltd. company profile

View the public company page for Nxera Pharma Co., Ltd. on 6ix.

Nxera Pharma Co., Ltd. news

Read company news and market updates connected to Nxera Pharma Co., Ltd..

Nxera Pharma Co., Ltd. investor events

Find investor webinars, events, and replay context for Nxera Pharma Co., Ltd..